Phreesia (NYSE:PHR) Price Target Lowered to $40.00 at KeyCorp

Phreesia (NYSE:PHR – Get Rating) had its target price lowered by KeyCorp from $45.00 to $40.00 in a report issued on Thursday morning, The Fly reports.

Other research analysts have also issued reports about the company. JMP Securities increased their price objective on Phreesia from $34.00 to $39.00 and gave the stock an outperform rating in a research report on Thursday, March 23rd. Stephens began coverage on Phreesia in a research report on Tuesday, April 11th. They set an overweight rating and a $37.00 price objective for the company. DA Davidson increased their target price on shares of Phreesia from $28.00 to $30.00 and gave the stock a neutral rating in a research note on Thursday, March 23rd. Piper Sandler lifted their price target on shares of Phreesia from $37.00 to $43.00 and gave the company an overweight rating in a research report on Wednesday, January 25th. Finally, Royal Bank of Canada increased their price objective on shares of Phreesia from $26.00 to $33.00 and gave the stock a sector perform rating in a research report on Thursday, March 23rd. Two investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of Moderate Buy and a consensus price target of $37.71.

Phreesia Price Performance

Shares of NYSE:PHR opened at $29.90 on Thursday. Phreesia has a 52-week low of $16.78 and a 52-week high of $40.00. The business has a fifty day moving average of $31.38 and a two-hundred day moving average of $32.20. The company has a debt-to-equity ratio of 0.01, a quick ratio of 3.32 and a current ratio of 3.32.

Phreesia (NYSE:PHR – Get Rating) last announced its quarterly earnings data on Wednesday, March 22nd. The company reported ($0.72) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.78) by $0.06. Phreesia had a negative net margin of 62.71% and a negative return on equity of 52.67%. The firm had revenue of $76.59 million during the quarter, compared to analyst estimates of $74.50 million. During the same quarter in the prior year, the firm posted ($0.90) earnings per share. Phreesia’s quarterly revenue was up 32.0% on a year-over-year basis. As a group, sell-side analysts predict that Phreesia will post -2.85 EPS for the current fiscal year.

Insider Buying and Selling

In other news, SVP Michael J. Davidoff sold 1,075 shares of Phreesia stock in a transaction dated Friday, April 21st. The stock was sold at an average price of $33.13, for a total value of $35,614.75. Following the completion of the transaction, the senior vice president now owns 95,773 shares in the company, valued at approximately $3,172,959.49. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, SVP Michael J. Davidoff sold 1,075 shares of Phreesia stock in a transaction that occurred on Friday, April 21st. The shares were sold at an average price of $33.13, for a total value of $35,614.75. Following the completion of the transaction, the senior vice president now owns 95,773 shares in the company, valued at $3,172,959.49. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Gillian Munson sold 3,555 shares of the stock in a transaction that occurred on Wednesday, May 10th. The shares were sold at an average price of $30.06, for a total transaction of $106,863.30. Following the completion of the sale, the director now directly owns 19,315 shares in the company, valued at $580,608.90. The disclosure for this sale can be found here. Insiders sold 26,863 shares of company stock valued at $834,743 in the last three months. 5.80% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Phreesia

Hedge funds and other institutional investors have recently made changes to their positions in the business. Captrust Financial Advisors boosted its holdings in Phreesia by 154.6% in the second quarter. Captrust Financial Advisors now owns 1,426 shares of the company’s stock valued at $36,000 after purchasing an additional 866 shares in the last quarter. Acadian Asset Management LLC acquired a new position in shares of Phreesia in the 1st quarter valued at $43,000. FourThought Financial LLC grew its position in shares of Phreesia by 16.4% in the 3rd quarter. FourThought Financial LLC now owns 3,081 shares of the company’s stock valued at $79,000 after buying an additional 434 shares during the last quarter. Tower Research Capital LLC TRC raised its stake in Phreesia by 85.4% during the 3rd quarter. Tower Research Capital LLC TRC now owns 3,137 shares of the company’s stock worth $80,000 after acquiring an additional 1,445 shares in the last quarter. Finally, Rockefeller Capital Management L.P. lifted its position in Phreesia by 610.2% in the third quarter. Rockefeller Capital Management L.P. now owns 4,524 shares of the company’s stock valued at $115,000 after acquiring an additional 3,887 shares during the last quarter. Institutional investors and hedge funds own 92.23% of the company’s stock.

Phreesia Company Profile

(Get Rating)

Phreesia, Inc engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products. Its solutions include health systems, multi-specialty, and federally qualified health centers (FQHCs).